CLPT (ClearPoint Neuro) Cyclically Adjusted Book per Share: $0.92 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CLPT ClearPoint Neuro Inc CLPT
63 GF Score
Price $14.66
GF Value $14.14
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is ClearPoint Neuro Cyclically Adjusted Book per Share?

ClearPoint Neuro CLPT -1.54% 63 Cyclically Adjusted Book per Share is $0.92 as of Jun. 2026. GuruFocus rates CLPT with a GF Score™ of 63/100 and a GF Value™ of $14.14 (Fairly Valued). The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

ClearPoint Neuro's adjusted book value per share for the three months ended in Jun. 2026 was $0.357. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.92 for the trailing ten years ended in Jun. 2026.

During the past 12 months, ClearPoint Neuro's average Cyclically Adjusted Book Growth Rate was 58.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-08-12), ClearPoint Neuro's current stock price is $14.66. ClearPoint Neuro's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was $0.92. ClearPoint Neuro's Cyclically Adjusted PB Ratio of today is 15.93.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of ClearPoint Neuro was 643.00. The lowest was 10.33. And the median was 29.47.


ClearPoint Neuro  (NAS:CLPT) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

ClearPoint Neuro's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=14.66/0.92
=15.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of ClearPoint Neuro was 643.00. The lowest was 10.33. And the median was 29.47.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


ClearPoint Neuro Cyclically Adjusted Book per Share Related Terms


ClearPoint Neuro Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for ClearPoint Neuro's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ClearPoint Neuro Cyclically Adjusted Book per Share Chart

ClearPoint Neuro Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.38 -0.57 -0.09 0.37 0.76

ClearPoint Neuro Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.58 0.71 0.76 0.84 0.92

CLPT vs SI, PACB, DCTH: Cyclically Adjusted Book per Share Comparison

For the Medical Devices subindustry, ClearPoint Neuro's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ClearPoint Neuro Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ClearPoint Neuro's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where ClearPoint Neuro's Cyclically Adjusted PB Ratio falls into.


CLPT
63GF Score
ClearPoint Neuro Inc CLPT
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ClearPoint Neuro Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, ClearPoint Neuro's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.357/333.9520*333.9520
=0.357

Current CPI (Jun. 2026) = 333.9520.

ClearPoint Neuro Quarterly Data

Book Value per Share CPI Adj_Book
201609 0.159 241.428 0.220
201612 -0.209 241.432 -0.289
201703 -0.609 243.801 -0.834
201706 0.825 244.955 1.125
201709 0.704 246.819 0.953
201712 0.545 246.524 0.738
201803 0.439 249.554 0.587
201806 0.323 251.989 0.428
201809 0.226 252.439 0.299
201812 0.137 251.233 0.182
201903 0.040 254.202 0.053
201906 0.505 256.143 0.658
201909 0.401 256.759 0.522
201912 0.301 256.974 0.391
202003 0.178 258.115 0.230
202006 0.086 257.797 0.111
202009 0.009 260.280 0.012
202012 0.139 260.474 0.178
202103 2.127 264.877 2.682
202106 2.149 271.696 2.641
202109 1.930 274.310 2.350
202112 2.061 278.802 2.469
202203 1.929 287.504 2.241
202206 1.749 296.311 1.971
202209 1.628 296.808 1.832
202212 1.501 296.797 1.689
202303 1.325 301.836 1.466
202306 1.113 305.109 1.218
202309 0.978 307.789 1.061
202312 0.859 306.746 0.935
202403 1.261 312.332 1.348
202406 1.165 314.175 1.238
202409 1.051 315.301 1.113
202412 0.919 315.605 0.972
202503 0.714 319.799 0.746
202506 0.695 322.561 0.720
202509 0.558 324.800 0.574
202512 0.954 324.054 0.983
202603 0.628 330.213 0.635
202606 0.357 333.952 0.357

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $0.92 mean?
ClearPoint Neuro (CLPT) has a Cyclically Adjusted Book per Share of $0.92 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on ClearPoint Neuro and its competitors.
Is ClearPoint Neuro's Cyclically Adjusted Book per Share too high?
ClearPoint Neuro's current Cyclically Adjusted Book per Share is $0.92. Overall, ClearPoint Neuro has a GF Score™ of 63/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does ClearPoint Neuro's Cyclically Adjusted Book per Share compare to SI and PACB?
ClearPoint Neuro's Cyclically Adjusted Book per Share of $0.92 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Book per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on ClearPoint Neuro and its competitors. ClearPoint Neuro's current Cyclically Adjusted Book per Share is $0.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ClearPoint Neuro stock overvalued right now?
Based on GuruFocus' analysis, ClearPoint Neuro (CLPT) is currently considered Fairly Valued. The stock's GF Value™ is $14.14, compared to a current price of $14.66 — trading 3.7% above its estimated fair value. The current Cyclically Adjusted Book per Share is $0.92. ClearPoint Neuro's overall GF Score™ is 63/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For ClearPoint Neuro (CLPT), the current Cyclically Adjusted Book per Share is $0.92 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ClearPoint Neuro (CLPT) Overvalued in 2026?

Based on GuruFocus' analysis, ClearPoint Neuro stock appears to be overvalued. The current stock price of $14.66 is trading 3.7% above its estimated GF Value™ of $14.14. GuruFocus considers ClearPoint Neuro to be Fairly Valued.

Key valuation signals for CLPT:

  • Cyclically Adjusted Book per Share: $0.92
  • GF Value™: $14.14 vs. price of $14.66 (3.7% above fair value)
  • GF Score™: 63/100 with 8 warning signs

No single metric tells the full story. See the CLPT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


ClearPoint Neuro Business Description

Address 120 S. Sierra Avenue, Suite 100, Solana Beach, CA, USA, 92075
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.
63GF Score

Get the complete analysis for CLPT

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$14.66
Price
$14.14
GF Value